PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

Epitope Diagnostics, Inc.

Press Release


Receive press releases from Epitope Diagnostics, Inc.: By Email PDF Version RSS Feeds:
Epitope Diagnostics, Inc. Introduces New 2-Hour Human ACTH ELISA Kit

Epitope Diagnostics releases a new, highly sensitive and robust human ACTH ELISA kit which can be completed in 2 hours, increasing the efficiency of clinical laboratory operations.

San Diego, CA, August 19, 2014 --(PR.com)-- Epitope Diagnostics is proud to introduce a new adrenocortocotropic hormone (ACTH) ELISA Kit, which measures ACTH levels with high sensitivity and robust assay performance characteristics.

The ELISA (enzyme-linked immunosorbent assay) platform is a popular method for accurate detection of various molecules. It is relatively easy to perform, inexpensive, and does not require specialized equipment, making it easy to perform in clinical laboratories of all sizes. One drawback, however, is that current ACTH ELISA kits on the market are 4-hour tests. Long incubation periods decrease the efficiency of the laboratory and occupy space in automated ELISA systems.

Epitope Diagnostics has put great effort into the development of a simplified, robust, 2-hour ACTH assay with a high analytical sensitivity (LLOD: 0.4 pg/mL) and dynamic range. The assay procedure essentially remains unchanged except for the shorter incubation period, making this an easy transition for laboratory staff.

ACTH levels outside the normal range is associated with of many different diseases, such as Addison’s disease, congenital adrenal hyperplasia, Cushing’s syndrome, multiple endocrine neoplasia type I, and hypopituitarism, thereby making it an important marker in the research and diagnosis of these diseases.

About Epitope Diagnostics, Inc.

Established since 2003, Epitope Diagnostics, Inc. is an ISO 13845 certified medical device manufacturing company located in the Sorrento Valley biotech hub of San Diego, California. They specialize in development and manufacture of products for the global medical device and diagnostics industry. Their areas of interest include gastrointestinal, cardiovascular, infectious and autoimmune disease, as well as tumors/cancers and calcium/bone metabolism.
Contact Information
Epitope Diagnostics, Inc.
Angela Gao
858-693-7877
Contact
www.epitopediagnostics.com

Click here to view the list of recent Press Releases from Epitope Diagnostics, Inc.
Promote Your Business